LEVI GRAVES: Open Payments
NPI 1720863871 · POCATELLO, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,728 in 98 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $762 · 2025 $1,728
Food & beverage: $1,616Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 21 | $471 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $456 |
| ABBVIE INC. | 25 | $301 |
| Vanda Pharmaceuticals Inc. | 8 | $147 |
| Axsome Therapeutics, Inc. | 5 | $97 |
| Alkermes, Inc. | 4 | $76 |
| Janssen Pharmaceuticals, Inc | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: CAPLYTA, VRAYLAR, UZEDY, AUSTEDO XR, FANAPT, Auvelity, LYBALVI, INVEGA SUSTENNA.
Industry payments across ID — which companies pay providers there.
